• PsyBio Therapeutics Corp. (PSYB) has closed the second tranche of a non-brokered private placement
  • Under the second tranche, the company issued 5,533,785 for gross proceeds of $276,689
  • Together with the first tranche, the company has raised gross proceeds of $909,970
  • PsyBio Therapeutics is an intellectual property-driven biotechnology company
  • Psybio Therapeutics Corp. (PSYB) opened trading at C$0.07

PsyBio Therapeutics Corp. (PSYB) has closed the second tranche of a non-brokered private placement.

Under the second tranche, the company issued 5,533,785 units priced at $0.05 per unit for gross proceeds of $276,689. Together with the first tranche, the company has raised gross proceeds of $909,970.

Each unit consists of one subordinate voting share and one common share purchase warrant exercisable at $0.10 per share for 24 months.

Warrants are subject to an acceleration clause.

All securities issued are subject to a statutory four-month hold period.

PsyBio Therapeutics is an intellectual property-driven biotechnology company developing psycho-targeted therapeutics to improve mental health and neurological conditions.

Psybio Therapeutics Corp. (PSYB) opened trading at C$0.07.

More From The Market Online

Tarku Resources acquires the Dana Project in Quebec

Tarku Resources (TSXV:TKU) acquires the Dana Project in Quebec, which hosts nickel, copper, cobalt and platinum group elements.

@ the Bell: TSX trips over the finish line

Investors on Tuesday lost a little more hope of an interest rate cut this year, but gains were made by mining and healthcare on…
POET - POET's dual LR4 transmit optical engine created for ADVA.

POET Technologies stock takes flight after Foxconn deal

Foxconn Interconnect Technology picks POET Technologies (TSXV:PTK) to provide optical engines for 800G and 1.6T optical transceiver modules.